Spruce Biosciences Balance Sheet Health
Financial Health criteria checks 5/6
Spruce Biosciences has a total shareholder equity of $76.5M and total debt of $3.3M, which brings its debt-to-equity ratio to 4.4%. Its total assets and total liabilities are $103.9M and $27.4M respectively.
Key information
4.4%
Debt to equity ratio
US$3.34m
Debt
Interest coverage ratio | n/a |
Cash | US$96.34m |
Equity | US$76.51m |
Total liabilities | US$27.44m |
Total assets | US$103.95m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: SPRB's short term assets ($102.2M) exceed its short term liabilities ($24.5M).
Long Term Liabilities: SPRB's short term assets ($102.2M) exceed its long term liabilities ($3.0M).
Debt to Equity History and Analysis
Debt Level: SPRB has more cash than its total debt.
Reducing Debt: SPRB's debt to equity ratio has increased from 0% to 4.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SPRB has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: SPRB has sufficient cash runway for 2.7 years if free cash flow continues to reduce at historical rates of 20.9% each year.